Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Hundreds of women have called for centralized management of their New Jersey state actions alleging Sanofi-Aventis and other drug companies failed to adequately warn consumers about the risk of permanent hair loss from using the breast cancer drug Taxotere.
The Federal Circuit on Wednesday affirmed two Patent Trial and Appeal Board inter partes review decisions that the asserted claims of patents owned by an Eli Lilly subsidiary covering the erectile dysfunction drug Cialis and pulmonary arterial hypertension drug Adcirca are invalid as obvious.
An Illinois federal judge on Tuesday dismissed with prejudice a lawsuit seeking to enforce a noncompete agreement against the former director of Medix Staffing Solutions Inc.’s pharmaceutical and biotechnology staffing division, saying the contract is overly broad and unenforceable.
The European Commission plans to fine Altice, Carl Icahn snapped up a less than 5 percent stake in Dell Technologies unit VMware, and Grail Inc. wants to raise $1 billion.
A Florida compounding pharmacy and its private equity fund owner on Tuesday urged a federal court to toss False Claims Act litigation accusing them of running a $68 million kickback scheme involving medically unnecessary prescriptions for Tricare beneficiaries, contending that the government's allegations are far too generalized.